Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model
- 31 August 2015
- journal article
- retracted article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 7 (46) , 19438-19447
Abstract
Tumor Initiating Cells (TICs) are resistant to radiotherapy and chemotherapy, and are believed to be responsible for tumor recurrence and metastasis. Combination therapies can overcome the limitation of conventional cancer treatments, and have demonstrated promising application in the clinic. Here, we show that dual modality radiotherapy (RT) and photothermal therapy (PTT) mediated by a single compartment nanosystem copper-64-labeled copper sulfide nanoparticles ([64Cu]CuS NPs) could suppress breast tumor metastasis through eradication of TICs. Positron electron tomography (PET) imaging and biodistribution studies showed that more than 90% of [64Cu]CuS NPs was retained in subcutaneously grown BT474 breast tumor 24 h after intratumoral (i.t.) injection, indicating the NPs are suitable for the combination therapy. Combined RT/PTT therapy resulted in significant tumor growth delay in the subcutaneous BT474 breast cancer model. Moreover, RT/PTT treatment significantly prolonged the survival of mice bearing orthotopic 4T1 breast tumors compared to no treatment, RT alone, or PTT alone. The RT/PTT combination therapy significantly reduced the number of tumor nodules in the lung and the formation of tumor mammospheres from treated 4T1 tumors. No obvious side effects of the CuS NPs were noted in the treated mice in a pilot toxicity study. Taken together, our data support the feasibility of a therapeutic approach for the suppression of tumor metastasis through localized RT/PTT therapy.Keywords
This publication has 34 references indexed in Scilit:
- Effects of Photoacoustic Imaging and Photothermal Ablation Therapy Mediated by Targeted Hollow Gold Nanospheres in an Orthotopic Mouse Xenograft Model of GliomaCancer Research, 2011
- Cancer Theranostics with Near-Infrared Light-Activatable Multimodal NanoparticlesAccounts of Chemical Research, 2011
- Comparison of Genomics and Functional Imaging from Canine Sarcomas Treated with Thermoradiotherapy Predicts Therapeutic Response and Identifies Combination TherapeuticsClinical Cancer Research, 2011
- A Chelator-Free Multifunctional [64Cu]CuS Nanoparticle Platform for Simultaneous Micro-PET/CT Imaging and Photothermal Ablation TherapyJournal of the American Chemical Society, 2010
- Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse modelsProceedings of the National Academy of Sciences, 2010
- Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical ResearchCancer Biotherapy and Radiopharmaceuticals, 2009
- Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurementsProceedings of the National Academy of Sciences, 2009
- Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)Accounts of Chemical Research, 2009
- Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living MiceSmall, 2009
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast CancerNew England Journal of Medicine, 2003